ci 994 and fluorouracil

ci 994 has been researched along with fluorouracil in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Janisch, L; Kimmel, KA; Kindler, HL; Macek, TA; Olson, SC; Ratain, MJ; Schilsky, RL; Undevia, SD; Vogelzang, NJ	1
Auernhammer, CJ; Ilhan, H; Jin, XF; Lindner, S; Maurer, J; Nölting, S; Orth, M; Spöttl, G	1

Trials

1 trial(s) available for ci 994 and fluorouracil

Article	Year
A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:11 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Capecitabine; Deoxycytidine; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Histone Deacetylase Inhibitors; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Phenylenediamines; Stomatitis; Thrombocytopenia; Treatment Outcome	2004

Article

Year

A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine.

Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:11

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Capecitabine; Deoxycytidine; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Histone Deacetylase Inhibitors; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Phenylenediamines; Stomatitis; Thrombocytopenia; Treatment Outcome

2004

Other Studies

1 other study(ies) available for ci 994 and fluorouracil

Article	Year
Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019, Volume: 60, Issue:9 Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Decitabine; Dose-Response Relationship, Radiation; Epigenesis, Genetic; Flow Cytometry; Fluorouracil; Histones; Humans; Microscopy, Fluorescence; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Phenylenediamines; Radiation-Sensitizing Agents; Receptors, Somatostatin; Tumor Suppressor p53-Binding Protein 1	2019

Article

Year

Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019, Volume: 60, Issue:9

Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Decitabine; Dose-Response Relationship, Radiation; Epigenesis, Genetic; Flow Cytometry; Fluorouracil; Histones; Humans; Microscopy, Fluorescence; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Phenylenediamines; Radiation-Sensitizing Agents; Receptors, Somatostatin; Tumor Suppressor p53-Binding Protein 1

2019